Black Race Does Not Independently Predict Adverse Outcome Following Radical Retropubic Prostatectomy at a Tertiary Referral Center

Journal of Urology

Volumn 176, Issue 2, 2006, Pages 515-519

  Nielsen, Matthew E ^a   Han, Misop ^b   Mangold, Leslie ^a   Humphreys, Elizabeth ^a   Walsh, Patrick C ^a   Partin, Alan W ^a   Freedland, Stephen J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

continental population groups; obesity; prostate specific antigen; prostatectomy; prostatic neoplasms

Indexed keywords

ADULT; ARTICLE; BIOCHEMISTRY; BODY MASS; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; GLEASON SCORE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEGRO; OBESITY; OUTCOME ASSESSMENT; PATHOLOGY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE; RADICAL RETROPUBIC PROSTATECTOMY; RISK ASSESSMENT; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE; SURGEON; TERTIARY HEALTH CARE; TIME SERIES ANALYSIS; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; REFERRAL AND CONSULTATION;

EID: 33745226205     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.03.100     Document Type: Article

References (20)

1. Ries L.A., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., et al. SEER Cancer Statistics Review 1973-1998 (2001), National Cancer Institute, National Institutes of Health, Bethesda, Maryland
2. Centers for Disease Control and Prevention (CDC). Recent trends in mortality rates for four major cancers, by sex and race/ethnicity-United States, 1990-1998. MMWR Morb Mortal Wkly Rep 51 (2002) 49
3. Epstein J.I., Pizov G., and Walsh P.C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71 (1993) 3582
4. Moul J.W., Wu H., Sun L., McLeod D.G., Amling C., Lance R., et al. Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen. an overview of the Department of Defense Center for Prostate Disease Research national database. Surgery 132 (2002) 213
5. Iselin C.E., Box J.W., Vollmer R.T., Layfield L.J., Robertson J.E., and Paulson D.F. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males. Cancer 83 (1998) 2353
6. Eastham J.A., and Kattan M.W. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol 163 (2000) 143
7. Cross C.K., Shultz D., Malkowicz S.B., Huang W.C., Whittington R., Tomaszewski J.E., et al. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. J Clin Oncol 20 (2002) 2863
8. Freedland S.J., Jalkut M., Dorey F., Sutter M.E., and Aronson W.J. Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. Urology 56 (2000) 87
9. Freedland S.J., Amling C.L., Dorey F., Kane C.J., Presti Jr. J.C., Terris M.K., et al. Race as an outcome predictor after radical prostatectomy. results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology 60 (2002) 670
10. Sohayda C.J., Kupelian P.A., Altman K.A., and Klein E.A. Race as an independent predictor of outcome after treatment for localized prostate cancer. J Urol 162 (1999) 1331
11. Powell I.J., Dey J., Dudley A., Pontes J.E., Cher M.L., Sakr W., et al. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer. a multivariable analysis. Urology 59 (2002) 907
12. Grossfeld G.D., Latini D.M., Downs T., Lubeck D.P., Mehta S.S., and Carroll P.R. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?. J Urol 168 (2002) 2510
13. Tarman G.J., Kane C.J., Moul J.W., Thrasher J.B., Foley J.P., Wilhite D., et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology 56 (2000) 1016
14. Moul J.W., Douglas T.H., McCarthy W.F., and McLeod D.G. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol 155 (1996) 1667
15. Powell I.J., Banerjee M., Bianco F.J., Wood Jr. D.P., Dey J., Lai Z., et al. The effect of race/ethnicity on prostate cancer treatment outcome is conditional. a review of Wayne State University data. J Urol 171 (2004) 1508
16. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76
17. Freedland S.J., Aronson W.J., Kane C.J., Presti Jr. J.C., Amling C.L., Elashoff D., et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized cancer. a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 22 (2004) 446
18. Amling C.L., Riffenburgh R.H., Sun L., Moul J.W., Lance R.S., Kusuda L., et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 22 (2004) 439
19. Freedland S.J., Terris M.K., Csathy G.S., Kane C.J., Amling C.L., Presti Jr. J.C., et al. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. J Urol 171 (2004) 2215
20. Freedland S.J., Humphreys E.B., Mangold L.A., Eisenberger M., Dorey F.J., Walsh P.C., et al. Risk of prostate cancer specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294 (2005) 433